Brisbane biotech secures $14 mn for drug discovery

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2013

Singapore: The University of Queensland-based biotechnology company Protagonist Therapeutics has secured $14 million in ...Read more

NZ firm migrates to Aus to capitalize on MS drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Sep, 2013

Singapore: New Zealand-based biopharmaceutical company Innate Immunotherapeutics is migrating to Australia in a move to ...Read more

Dengue incurs annual cost of $950 mn to SE Asia

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 3 Comment | 20 Jun, 2014

Philippines: The economic burden churned by mosquito borne disease, dengue, is costing upto $950 million to south east A...Read more

NSC lung cancer drug pipeline is strong: Analyst

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 1 Comment | 11 Nov, 2014

Singapore: Non-Small Cell Lung Cancer (NSCLC) treatment pipeline has a diverse selection of 122 first-in-class products ...Read more

Are declining Ebola cases a challenge for clinical studies?

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 3 Comment | 16 Mar, 2015

Singapore: The steady decline in new ebola cases presents a formidable challenge to current and future clinical trials o...Read more

BMS releases $3.5 mn fund for Hep B&C in India, China

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Dec, 2014

Singapore: Bristol-Myers-Squibb Foundation has released nine new grants totaling to around $3.5 million towards hepatiti...Read more

AMRI acquires Cedarburg at $41mn

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Apr, 2014

Singapore: AMRI has completed the acquisition of Cedarburg Pharmaceuticals, a contract developer and manufacturer of tec...Read more

Latanoprost improves glucose, lipid disorder in diabetes

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Sep, 2013

Singapore: Researchers from Shanghai Institute of Materia Medica, Chinese Academy of Science, have discovered that Latan...Read more

QRxPharma refiles Moxduo NDA with FDA

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 Nov, 2013

Singapore: Australia-based QRxPharma has resubmitted its Moxduo new drug application (NDA) after the US Food and Drug Ad...Read more

Eli Lilly partners with BioNTech to develop cancer immunotherapies

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 12 May, 2015

Singapore: Eli Lilly has partnered with German firm, BioNTech, to discover novel cancer immunotherapies through body's o...Read more

Boehringer Ingelheim collaborates with Harvard University

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2012

Singapore: Boehringer Ingelheim has established a translational research collaboration with the presidents and fellows o...Read more

Zydus Cadila launches indigenous diabetes drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2013

Singapore: Indian pharma company Cadila Healthcare that operates under the aegis of Zydus Group, has launched its patent...Read more

Astellas receives approval of Irribow in Japan

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Aug, 2013

Singapore: Astellas Pharma has obtained the marketing approval of Irribow OD 1 Tablets 2.5µg / 5µg (generic name: ramo...Read more

Biotron to report data from hepatitis C trial

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 Oct, 2012

Singapore: Biotron, a clinical-stage drug development company focused on development of new generation antiviral drugs, ...Read more

Biocon's novel anti-psoriasis biotech drug Itolizumab released in India

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 12 Aug, 2013

After geting the regulatory approval in early 2013, Biocon, India's number two biotech company by revenues, released the...Read more

Bioventus gets global rights for Pfizer's bone portfolio

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jul, 2013

Singapore: Bioventus, which specializes in active orthopaedic healing, has acquired exclusive, worldwide license to Pfiz...Read more

Merck to halt Parkinson's trial due to lack of efficacy

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 May, 2013

Singapore: Merck, known as Merck Sharp & Dohme (MSD) outside the US and Canada, provided update on its clinical prog...Read more

Hong Kong to host international TCM exhibition, conference

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 12 Aug, 2013

Singapore: Hong Kong Trade Development Council (HKTDC) and Modernized Chinese Medicine International Association (MCMIA ...Read more